• Experts
  • Supporters
  • About Mirrors of Medicine
Home
  • Disease Area
    • Bladder cancer
    • Breast cancer
    • Chronic pain
    • COVID-19
    • Lower Urinary Tract Dysfunction
    • Prostate cancer
    • Renal Cell Carcinoma
  • Method
  • Accreditation
  • my dashboard
  • Join
  • Login
  • EN
    EN FR DE IT ES RU UK
  • Bladder cancer
  • Breast cancer
  • Chronic pain
  • COVID-19
  • Lower Urinary Tract Dysfunction
  • Prostate cancer
  • Renal Cell Carcinoma
  • Method
  • Accreditation
  • Method
  • Experts
  • Supporters
  • Principles
  • About Mirrors of Medicine
  • Contact

Renal Cell Carcinoma

Second-line therapy in metastatic ccRCC

  • Editor in chief
  • Experts & associates
  • Background & relevance
  • Last update: 09-07-2021

View the PinPoint cases (
) and get feedback

Progression after TKI (1)
Progression after TKI (2)
Progression after immuno-oncologic therapy
Progression after TKI and rechallenge (1)
Progression after TKI and rechallenge (2)

Do the QuickScan and see where you are in comparison to your colleagues!

Continue with an accredited CME course and earn 1 ECMEC

Study 5 cases, answer 10 questions and earn 1 ECMEC

Feedback

Help us to improve the PPCP platform

Home
PinPoint Case Platform

Essential clinical questions addressed by short cases with targeted feedback

  • How we work
    • Method
    • Experts
    • Supporters
    • About Mirrors of Medicine
    • Newsletter
  • Disease areas
    • Bladder cancer
    • Breast cancer
    • Chronic pain
    • COVID-19
    • Lower Urinary Tract Dysfunction
    • Prostate cancer
    • Renal Cell Carcinoma
  • Contact
    • Contact us footer.contact_click_image info@mirrorsofmedicine.org
    • Privacy policy
    • Terms & Conditions

© Copyright 2022 Mirrors of Medicine